Corey McMillan, PhD is associate professor of neurology at the Perelman School of Medicine and a member of the Neuroscience Graduate Group and Institute for Translational Medicine and Therapeutics. Dr. McMillan holds a bachelor’s degree in psychology and cognitive neuroscience from Temple University, a master’s of science in psycholinguistics from the University of Edinburgh, and a PhD in psychology from the University of Edinburgh.

Dr. McMillan’s research focuses on identifying cognitive and biological markers of neurodegenerative diseases like frontotempoeral lobar degeneration, amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. His cognitive research focuses on the social and decision-making mechanisms that contribute to language processing deficits associated with neurodegenerative diseases. His biological research uses neuroimaging, genetics, and biofluids in an effort to improve early diagnosis and predict which protein is causing a disease in patients. Dr. McMillan’s biomarker research leverages sophisticated bioinformatic and statistical approaches to integrate multiple data sources in effort to identify precision medicine approaches for treating individual patients. Ultimately, Dr. McMillan intends to integrate cognitive and biological tests to develop powerful methods for identifying patients for entry into clinical trials and for measuring the efficacy of drug treatments in the context of clinical trials.